2m 2m 2m 2m 2m 2m 2m
Zoetis-A (ZTS)
NYSE
$82.57+$0.11 (+0.13%)
Price as of Nov 11, 2026 7:57 PM EST- $33.5BMarket Cap
- -29.80%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Zoetis-A (ZTS)
$82.57+$0.11 (+0.13%)
ZTS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $82.46 | ||
Change | +$0.14 (+0.17%) | ||
Open | $81.75 | ||
High | $83.28 | ||
Low | $80.43 | ||
Previous Close | $82.32 | ||
Volume | 4,894,311 | ||
30-Day Average Volume | 4,575,215 | ||
1-Week Change | -0.64% | ||
1-Month Change | 10.97% | ||
1-Year Change | -29.80% | ||
3-Year Change | -49.04% | ||
5-Year Change | -59.50% | ||
Fundamentals | |||
Shares Outstanding | 406.3M | ||
Total Assets | $15.1B | ||
Market Cap | $33.5B | ||
Enterprise Value | $41.2B | ||
Period: QTR TTM FY | |||
Revenue | $2.4B | ||
Net Income | $591.0M | ||
Free Cash Flow | $717.0M | ||
EBIT | $791.0M | ||
EBITDA | $910.0M | ||
Net Working Capital | $3.6B | ||
EPS | $1.44 | ||
Enterprise Value/EBITDA | 45 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 10 | ||
P/E | 57 | ||
PEG | -4 | ||
Price/Free Cash Flow | 47 | ||
Price/Operating Cash Flow | 41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.57% | ||
Trailing Annual Dividend Yield | 2.57% | ||
Ex-Dividend Date | 10/30/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield